Switching Patterns Examined for Newly Initiated TNFi Therapy in Ankylosing Spondylitis
Data show that two-thirds of patients with ankylosing spondylitis did not remain on their index TNFi therapy 2 years after treatment initiation.
Spondyloarthritis
Disease Burden, Characteristics of Psoriatic Arthritis Examined
Researchers evaluated the prevalence, treatment patterns, disease characteristics, and comorbid diseases among people in Denmark with psoriatic arthritis.
Screening Tool Identifies Psoriatic Arthritis in Patients With Psoriasis
The investigators sought to evaluate the risk for possible undiagnosed psoriatic arthritis in patients with psoriasis.
Long-Term Exposure to TNFi Therapy May Not Affect Fertility in Men With Spondyloarthritis
Pregnancy and offspring outcomes were reassuring in couples where men with spondyloarthritis (SpA) were exposed to tumor necrosis factor inhibitors (TNFi), according to results from a study published in The Journal of Rheumatology. Researchers conducted a multicenter prospective study of 202 men with SpA who were exposed to TNFi therapy for a minimum of 12…
Effects of Physical Activity, Medication Use Evaluated in Psoriatic Arthritis
Investigators examined the associations between ultrasound changes in entheses and clinical characteristics in patients with psoriatic arthritis.
Efficacy and Safety of Tofacitinib vs Apremilast in Psoriatic Arthritis
Tofacitinib 10 mg and apremilast 30 mg were the most efficacious interventions for patients with active psoriatic arthritis.
Efficacy, Safety of Intravenous Golimumab Maintained Through 1 Year in Ankylosing Spondylitis
Researchers measured the safety and efficacy of intravenous golimumab in patients with active ankylosing spondylitis through 1 year.
Psoriatic Arthritis Disease Activity Frequently Improves During Pregnancy, Flares Postpartum
Pregnant women with psoriatic arthritis generally experienced a reduction in disease activity during pregnancy and flared postpartum.
Concurrent TNFi, DMARD Therapy May Benefit Overweight Patients With Axial Spondyloarthritis
The use of csDMARDs with TNFi may increase the likelihood of achieving clinical response in overweight or obese patients with axial spondyloarthritis.
Intravenous Golimumab Effective for Preventing Radiographic Progression in Psoriatic Arthritis
Researchers evaluated the effects of intravenous golimumab on radiographic progression in psoriatic arthritis.
Next post in Psoriatic Arthritis
